Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

14.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.0K
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

9.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.4K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.4K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

21
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
21
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

332
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
332

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting DNA-binding protein and coronavirus protein flexibility using protein dihedral angle and sequence feature.

Proteins·2022
Same author

PseAraUbi: predicting arabidopsis ubiquitination sites by incorporating the physico-chemical and structural features.

Plant molecular biology·2022
Same author

Predicting DNA binding protein-drug interactions based on network similarity.

BMC bioinformatics·2020
Same author

SmoPSI: Analysis and Prediction of Small Molecule Binding Sites Based on Protein Sequence Information.

Computational and mathematical methods in medicine·2019
Same author

[Identification of Placenta hominis and its adulterants using COI barcode].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2014
Same author

Two new species of Austrophthiracarus (Acari: Oribatida: phthiracaridae) from New Zealand.

Zootaxa·2014

Related Experiment Video

Updated: Oct 13, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.9K

PPDTS: Predicting potential drug-target interactions based on network similarity.

Wei Wang1,2,3, Yongqing Wang1, Yu Zhang1

  • 1College of Computer and Information Engineering, Henan Normal University, Xinxiang, China.

IET Systems Biology
|November 16, 2021
PubMed
Summary

This study introduces PPDTS, a novel computational method for predicting drug-target interactions (DTIs) by analyzing local network structures. PPDTS demonstrates superior performance compared to existing methods, aiding drug discovery.

Keywords:
Big Databiocomputingbioinformaticsbiology computingdrugs

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.4K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.0K

Related Experiment Videos

Last Updated: Oct 13, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.9K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.4K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.0K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Drug discovery

Background:

  • Identifying drug-target interactions (DTIs) is crucial for drug discovery but remains computationally challenging.
  • Existing computational methods often rely on global network similarity, which has limitations.

Purpose of the Study:

  • To propose a novel computational method, PPDTS, for predicting DTIs.
  • To leverage the local structure of drug-target association networks for improved prediction accuracy.

Main Methods:

  • Converted known DTIs into a binary network based on local structure.
  • Employed the Resource Allocation algorithm to generate drug-drug and target-target similarity networks.
  • Utilized Collaborative Filtering with known topology for similarity scores.
  • Developed a linear combination of drug-target and target-drug similarity models for final predictions.

Main Results:

  • The proposed PPDTS method significantly outperformed four popular network-based similarity methods.
  • Experimental validation on diverse datasets confirmed PPDTS's superior performance.
  • Some predicted DTIs were corroborated by entries in UniProt and DrugBank databases.

Conclusions:

  • PPDTS offers a more effective approach to predicting DTIs by focusing on local network structures.
  • The method shows promise for accelerating the drug discovery pipeline.
  • Further validation and application of PPDTS can enhance the identification of potential drug candidates.